Ning Jia - Tianan Pharmaceutical Director
| TNPH Stock | USD 0.01 0.00 0.00% |
Director
Mr. Jia is director of Tianan Pharmaceutical Co since 2003. Since 1994 Mr. Jia has also been a partner with Xian Gelin Healthcare Research Institute, a research and development firm. since 2003.
| Age | 52 |
| Tenure | 21 years |
| Phone | 86 29 8538 1587 |
| Web | http://www.Xatazy.com |
Tianan Pharmaceutical Management Efficiency
The company has return on total asset (ROA) of 0.1801 % which means that it generated a profit of $0.1801 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.2512 %, meaning that it created $0.2512 on every $100 dollars invested by stockholders. Tianan Pharmaceutical's management efficiency ratios could be used to measure how well Tianan Pharmaceutical manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Sander Flaum | Eagle Pharmaceuticals | 81 | |
| Bosun Hau | Evolus Inc | 39 | |
| David Pernock | Eagle Pharmaceuticals | 63 | |
| Peter Farrell | Evolus Inc | 75 | |
| Robert Pettway | cbdMD Inc | N/A | |
| Kristine Romine | Evolus Inc | 53 | |
| Robert Glenning | Eagle Pharmaceuticals | 57 | |
| Karah Parschauer | Evolus Inc | 40 | |
| Alain Schreiber | Eagle Pharmaceuticals | 58 | |
| David Gill | Evolus Inc | 63 | |
| Richard Edlin | Eagle Pharmaceuticals | 57 | |
| Michael Graves | Eagle Pharmaceuticals | 61 | |
| Robert Hayman | Evolus Inc | 59 | |
| Edward Kay | Eagle Pharmaceuticals | N/A | |
| Douglas Braunstein | Eagle Pharmaceuticals | 57 | |
| Simone Blank | Evolus Inc | 55 | |
| Steven Ratoff | Eagle Pharmaceuticals | 81 | |
Management Performance
| Return On Equity | 0.25 | |||
| Return On Asset | 0.18 |
Tianan Pharmaceutical Leadership Team
Elected by the shareholders, the Tianan Pharmaceutical's board of directors comprises two types of representatives: Tianan Pharmaceutical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Tianan. The board's role is to monitor Tianan Pharmaceutical's management team and ensure that shareholders' interests are well served. Tianan Pharmaceutical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Tianan Pharmaceutical's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Deshun Li, Director | ||
| Lie Wei, Chief Officer | ||
| Jianjun Weng, CEO and Director | ||
| Yanqing Wang, Director | ||
| Peng Xi, Chief Marketing Officer | ||
| Ning Jia, Director | ||
| Renhua Wang, Secretary | ||
| Mingqi Sun, Chief Quality Officer | ||
| Zhiguo Ma, Director | ||
| Hailiang Xue, Chief Production Officer | ||
| Ping Ren, Director | ||
| Andong Jia, Chief Admin. Officer | ||
| Huachu Tang, Chief Investment Officer | ||
| Wei Li, Chief Financial and Accounting Officer | ||
| Jinming Gao, Director | ||
| Hongwei Wang, Director |
Tianan Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Tianan Pharmaceutical a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.25 | |||
| Return On Asset | 0.18 | |||
| Profit Margin | 0.30 % | |||
| Operating Margin | 0.36 % | |||
| Current Valuation | 979.64 K | |||
| Price To Earning | 0.15 X | |||
| Price To Book | 1.20 X | |||
| Price To Sales | 1.62 X | |||
| Revenue | 10.65 M | |||
| Gross Profit | 7.3 M |
Currently Active Assets on Macroaxis
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Tianan Pharmaceutical Co. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Complementary Tools for Tianan Pink Sheet analysis
When running Tianan Pharmaceutical's price analysis, check to measure Tianan Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tianan Pharmaceutical is operating at the current time. Most of Tianan Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Tianan Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tianan Pharmaceutical's price. Additionally, you may evaluate how the addition of Tianan Pharmaceutical to your portfolios can decrease your overall portfolio volatility.
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Stocks Directory Find actively traded stocks across global markets | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities |